Chairman of the Board and Chief Executive Officer at Madrigal Pharmaceuticals, Inc.
Dr. Friedman has more than 40 years of development and commercial pharmaceutical experience. He is the former CEO of Incyte Pharmaceuticals, former president of DuPont Pharmaceuticals and a former Associate Professor of Medicine & Pharmacology at Harvard Medical School. Dr. Friedman is a diplomat of the American Board of Internal Medicine and he also serves on the Board of Directors of Prelude Therapeutics (Nasdaq: PRLD).
Source: Madrigal Pharmaceuticals, Inc. on 06/24/2022
By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Paul A. Friedman M.D.. More specifically, you'll be able to:
Access over 1,500,000 executive and board member profiles.
Example: Paul A. Friedman M.D.